Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw unusually-high trading volume on Monday . Approximately 8,000 shares traded hands during mid-day trading, an increase of 29% from the previous session’s volume of 6,217 shares.The stock last traded at $8.00 and had previously closed at $8.02.
Oxford BioMedica Trading Up 0.4%
The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89. The firm has a 50 day simple moving average of $8.17 and a two-hundred day simple moving average of $6.32.
About Oxford BioMedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Articles
- Five stocks we like better than Oxford BioMedica
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NVIDIA Nears Buy Zone as Rumors Swirl About China Chip Deal
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- These 3 Tech Companies Are Suddenly Paying Bigger Dividends
- Top Stocks Investing in 5G Technology
- Holiday Spending to Hit $1 Trillion—Time to Buy This Retail ETF?
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
